Rapidly progressive cognitive impairment resulting in heavy psychosocial burden in a patient with Fabry disease undergoing hemodialysis: a case report

被引:0
作者
Ohsawa, Isao [1 ,2 ]
Onuki, Akiko [2 ]
Oka, Fumie [2 ,3 ]
Matsuoka, Yoshiyuki [4 ]
Makita, Yuko [5 ]
Kobayashi, Takashi [5 ]
Kanaguchi, Yasuhiko [5 ]
Nakamura, Yuya [1 ]
Suzuki, Yusuke [5 ]
Goto, Yoshikazu [4 ]
Gotoh, Hiromichi [1 ]
机构
[1] Saiyu Soka Hosp, Dept Nephrol, Internal Med, 1-7-22 Matsubara, Soka, Saitama 3400041, Japan
[2] Saiyu Soka Hosp, Dept Rehabil, Soka, Saitama, Japan
[3] Japanese Red Cross Med Ctr, Dept Psychiat, Shibuya Ku, Tokyo, Japan
[4] Saiyu Soka Hosp, Dept Neurosurg, Soka, Saitama, Japan
[5] Juntendo Univ, Fac Med, Dept Internal Med, Div Nephrol, Bunkyo Ku, Tokyo, Japan
关键词
Fabry disease; Enzyme replacement therapy; Agalsidase alfa; Hemodialysis; Cognitive impairment; Hasegawa dementia rating scale; Mini-mental state examination; ENZYME REPLACEMENT THERAPY; SYMPTOMS;
D O I
10.1186/s12882-024-03624-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background Long-term enzyme replacement therapy (ERT) may improve prognosis in the patients with Fabry disease (FD), however, detail psychosocial burden has not been focused on long life expectancy. We experienced a male case of FD under ERT, he was placed on hemodialysis and presented rapidly progressive cognitive function.Case presentation A 51-year-old male patient with FD has been receiving ERT from age of 38 years. Hemodialysis was initiated at the age of 47 years. The patient experienced several attacks of cerebral infarction, and brain images demonstrated wide-spread asymptomatic ischemic lesions. His behavior became problematic at the age of 51 years. He often exhibited restlessness during hemodialysis sessions and failure to communicate effectively. The patient experienced impairment of attention and executive function, topographical disorientation, and amnesia. Consequently, it was necessary for medical staff and family members to monitor his behavior for safe extracorporeal circulation and daily life activities. Annual standardized neuropsychiatric testing revealed worsening of cognitive performance.Conclusions Despite treating with long-term ERT, it is necessary to determine the psychosocial burden derived from the progression of cognitive impairment in patients with FD undergoing hemodialysis.
引用
收藏
页数:7
相关论文
共 21 条
  • [1] Cognitive dysfunction and depression in Fabry disease: a systematic review
    Bolsover, Fay E.
    Murphy, Elaine
    Cipolotti, Lisa
    Werring, David J.
    Lachmann, Robin H.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2014, 37 (02) : 177 - 187
  • [2] Enzyme Replacement Therapy Stabilized White Matter Lesion Progression in Fabry Disease
    Fellgiebel, Andreas
    Gartenschlaeger, Martin
    Wildberger, Kerstin
    Scheurich, Armin
    Desnick, Robert J.
    Sims, Katherine
    [J]. CEREBROVASCULAR DISEASES, 2014, 38 (06) : 448 - 456
  • [3] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN
    FOLSTEIN, MF
    FOLSTEIN, SE
    MCHUGH, PR
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) : 189 - 198
  • [4] Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease
    Germain, Dominique P.
    Charrow, Joel
    Desnick, Robert J.
    Guffon, Nathalie
    Kempf, Judy
    Lachmann, Robin H.
    Lemay, Roberta
    Linthorst, Gabor E.
    Packman, Seymour
    Scott, C. Ronald
    Waldek, Stephen
    Warnock, David G.
    Weinreb, Neal J.
    Wilcox, William R.
    [J]. JOURNAL OF MEDICAL GENETICS, 2015, 52 (05) : 353 - 358
  • [5] Voxel-based morphometry to discriminate early Alzheimer's disease from controls
    Hirata, Y
    Matsuda, H
    Nemoto, K
    Ohnishi, T
    Hirao, K
    Yamashita, F
    Asada, T
    Iwabuchi, S
    Samejima, H
    [J]. NEUROSCIENCE LETTERS, 2005, 382 (03) : 269 - 274
  • [6] The beneficial effects of long-term enzyme replacement therapy on cardiac involvement in Japanese Fabry patients
    Hongo, Kenichi
    Ito, Keiichi
    Date, Taro
    Anan, Ikuko
    Inoue, Yasunori
    Morimoto, Satoshi
    Ogawa, Kazuo
    Kawai, Makoto
    Kobayashi, Hiroshi
    Kobayashi, Masahisa
    Ida, Hiroyuki
    Ohashi, Toya
    Taniguchi, Ikuo
    Yoshimura, Michihiro
    Eto, Yoshikatsu
    [J]. MOLECULAR GENETICS AND METABOLISM, 2018, 124 (02) : 143 - 151
  • [7] Imai Y., 1994, Hong Kong Journal of Psychiatry, V4, P20, DOI 1G1.170193987
  • [8] Itoh Kazuko, 2005, Nihon Jinzo Gakkai Shi, V47, P121
  • [9] Kiernan R., 1995, COGNISTAT: The Neurobehavioral Cognitive Status Examination manual
  • [10] Cognitive functioning and depressive symptoms in Fabry disease: A follow-up study
    Korver, Simon
    Geurtsen, Gert J.
    Hollak, Carla E. M.
    van Schaik, Ivo N.
    Longo, Maria G. F.
    Lima, Marjana R.
    Dijkgraaf, Marcel G. W.
    Langeveld, Mirjam
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2020, 43 (05) : 1070 - 1081